Limited research suggests a strong association between adult Attention Deficit Hyperactivity Disorder (ADHD) and substance use disorders (SUD), with adult ADHD over-represented among people with substance use problems (20-40% prevalence).
Patterns of alcohol and drug use
There has been a recent increase in the prescribing of pharmaceutical opioids to Chronic Non-Cancer Pain (CNCP) patients in Australia which has led to increasing professional and public concern about the use and harms that may be related to such use.
NIDIP was established in the recognition that there was a greater need for the regular dissemination of trends in the epidemiology of drug-related harms in Australia.
There are growing efforts by pharmaceutical companies to develop opioid formulations that are less prone to misuse (particularly injection), dependence and diversion to illicit markets.
This project forms the basis of Lucy Albertella’s PhD. It is a longitudinal study of cannabis use, schizotypy and attentional inhibition in a sample of 14-24 year olds.
Men have traditionally reported higher rates of alcohol and other substance use than women, however there is emerging evidence that women’s levels of substance use may be ‘catching up’ to men’s. This study involves a comprehensive review of the international literature to assess if there is evid
Attention Deficit Hyperactivity Disorder (ADHD) is a significant risk factor for the development of substance use disorders (SUD) in adolescence and adulthood, and ADHD complicates the course and treatment of SUD.
This study aimed to provide novel data on Australian fatalities involving steroids.
Alcohol-related harms contribute substantially to the burden of disease in Australia, with a wide range of acute and chronic consequences associated with alcohol consumption.